| Names | |
|---|---|
| Preferred IUPAC name N,N′-Bis[3-(4,5-dihydro-1H-imidazol-2-yl)phenyl]urea | |
| Other names Imizocarb; Imizol; Diamidine | |
| Identifiers | |
3D model (JSmol) | |
| ChemSpider | |
| ECHA InfoCard | 100.044.268 |
PubChem CID | |
| UNII | |
CompTox Dashboard (EPA) | |
| |
| |
| Properties | |
| C19H20N6O | |
| Molar mass | 348.410 g·mol−1 |
| Pharmacology | |
| QP51EX01 ( WHO ) | |
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa). | |
Imidocarb is a urea derivative used in veterinary medicine as an antiprotozoal agent for the treatment of infection with Babesia (babesiosis) and other parasites. [1] [2] [3]
Imidocarb is anticholinergic; it inhibits acetylcholinesterase. [4] [5]